New eye Drug's early effects under the microscope in wet AMD study

NCT ID NCT07434713

Recruiting now Knowledge-focused Sponsor: Insel Gruppe AG, University Hospital Bern Source: ClinicalTrials.gov ↗

First seen Mar 11, 2026 · Last updated Apr 29, 2026 · Updated 7 times

Summary

This study is observing 50 people with wet age-related macular degeneration (AMD) to see how quickly a high-dose eye injection (Eylea 8mg) dries up fluid in the retina. Researchers will use special scans to measure fluid changes and vision improvements over the first two months. The goal is to better understand early treatment response, not to test a new cure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION (AMD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Dept. of Ophthalmology, University Hospital, Inselspital
RECRUITING

Bern, 3010, Switzerland

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.